Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine J Landis

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta. Reviews on Cancer|January 30, 2018
The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cellsCatherine J Landis, Anh Nhat Tran, Sarah E Scott, et al.
Cells|June 24, 2022
Targeting Acid Ceramidase Inhibits Glioblastoma Cell Migration through Decreased AKT SignalingCyntanna C Hawkins, Amber B Jones, Emily R Gordon, et al.
ACS Chemical Biology|June 16, 2018
Identification of Compounds That Decrease Glioblastoma Growth and Glucose Uptake in VitroCatherine J Landis, Sixue Zhang, Gloria A Benavides, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2022
Ghost mitochondria drive metastasis through adaptive GCN2/Akt therapeutic vulnerabilityJagadish C Ghosh, Michela Perego, Ekta Agarwal, et al.
JCI Insight|December 22, 2017
Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivoNathaniel H Boyd, Kiera Walker, Joshua Fried, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta. Reviews on Cancer|January 30, 2018
The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cellsCatherine J Landis, Anh Nhat Tran, Sarah E Scott, et al.
Cells|June 24, 2022
Targeting Acid Ceramidase Inhibits Glioblastoma Cell Migration through Decreased AKT SignalingCyntanna C Hawkins, Amber B Jones, Emily R Gordon, et al.
ACS Chemical Biology|June 16, 2018
Identification of Compounds That Decrease Glioblastoma Growth and Glucose Uptake in VitroCatherine J Landis, Sixue Zhang, Gloria A Benavides, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2022
Ghost mitochondria drive metastasis through adaptive GCN2/Akt therapeutic vulnerabilityJagadish C Ghosh, Michela Perego, Ekta Agarwal, et al.
JCI Insight|December 22, 2017
Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivoNathaniel H Boyd, Kiera Walker, Joshua Fried, et al.
Pageof 1